Biocon appoints Christiane Hamacher as CEO of Biocon Biologics India

"Christiane joins us at a critical inflexion point in the business as we build our stature in the large and growing opportunity for biosimilar biologics. I am confident that she will successfully lead the company to become a major global player in the near future," Biocon Chairperson and Managing Director Kiran Mazumdar-Shaw said.

Bengaluru: Biotechnology major Biocon announced that Dr Christiane Hamacher has been appointed as CEO of Biocon Biologics India Ltd., effective from Friday.

Biocon Biologics India Ltd. is a wholly-owned subsidiary of Biocon Ltd.

Read Also: Oops- Biocon chief fined Rs 9.5 lakh by Infosys

Hamacher comes with more than 20 years of leadership experience in both strategic and operational roles across the value chain in global pharma, spanning Asia, Europe and the US, Biocon said in a release.

She has been with Roche, Basel, Switzerland since 2007 and prior to that spent 10 years at Schering AG, Berlin, Germany, it said.

"Christiane joins us at a critical inflexion point in the business as we build our stature in the large and growing opportunity for biosimilar biologics. I am confident that she will successfully lead the company to become a major global player in the near future," Biocon Chairperson and Managing Director Kiran Mazumdar-Shaw said.

Biocon said, during her long career in the pharmaceutical industry, Hamacher has built expertise in the areas of oncology, virology, CNS, cardiovascular, gynaecology, diagnostics, dermatology, rheumatology and rare diseases.

Read Also: Biocon chief Kiran Shaw says it's a struggle to find adequate number of women for leadership roles